Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

This study is currently recruiting participants.
Verified June 2011 by QR Pharma Inc.
Sponsor:
Information provided by:
QR Pharma Inc.
ClinicalTrials.gov Identifier:
NCT01072812
First received: February 19, 2010
Last updated: June 11, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)